Berntsen David A, Ticak Anita, Orr Danielle J, Giannoni Amber Gaume, Sinnott Loraine T, Mutti Donald O, Jones-Jordan Lisa A, Walline Jeffrey J
University of Houston College of Optometry, Houston, Texas.
The Ohio State University College of Optometry, Columbus.
JAMA Ophthalmol. 2025 Feb 1;143(2):155-162. doi: 10.1001/jamaophthalmol.2024.5885.
For myopia control to be beneficial, it would be important that the benefit of treatment (slowed eye growth) is not lost because of faster than normal growth (rebound) after discontinuing treatment.
To determine whether there is a loss of treatment effect (rebound) after discontinuing soft multifocal contact lenses in children with myopia.
DESIGN, SETTING, AND PARTICIPANTS: The Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study involved children with myopia (aged 11-17 years at BLINK2 baseline) who completed the BLINK Study randomized clinical trial. Enrollment was from September 2019 through January 2021; follow-up was completed in January 2024. In the BLINK2 Study, all children wore high-add (+2.50 diopter [D]) multifocal soft contact lenses for 2 years and single-vision soft contact lenses during the third year to determine if rebound occurred.
High-add multifocal soft contact lenses and single-vision soft contact lenses.
Eye length (optical biometry) and refractive error (cycloplegic autorefraction) were measured annually.
Of 248 participants enrolled in BLINK2, 235 completed the study. The median age at the baseline visit was 15 years (range, 11-17 years); 146 participants (59%) were female, and 102 (41%) were male. At baseline for BLINK2, mean (SD) axial length and spherical equivalent refractive error were 25.2 (0.9) mm and -3.40 (1.40) D, respectively. After participants switched from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm per year (95% CI, 0.01 to 0.05) regardless of their original BLINK treatment assignment (P = .81). There was also an increase in myopia progression after switching to single-vision lenses of -0.17 D per year (95% CI, -0.22 to -0.12) that did not depend on the original BLINK treatment assignment (P = .57). There continued to be a difference in axial length and refractive error throughout BLINK2 based on the BLINK Study treatment assignment with the original high-add group having shorter eyes and less myopia than the original medium-add (+1.50 D) and single-vision groups.
The BLINK2 Study found no evidence of a loss of treatment effect after discontinuing multifocal contact lenses in older teenagers. These data suggest eye growth and myopia progression returned to faster but age-expected rates and support continuing multifocal lenses until cessation of elongation and progression.
为使近视控制有益,重要的是治疗益处(减缓眼轴生长)不会因停止治疗后比正常生长更快(反弹)而丧失。
确定近视儿童停用软性多焦点隐形眼镜后是否存在治疗效果丧失(反弹)。
设计、设置和参与者:近视儿童双焦点镜片2(BLINK2)队列研究纳入了近视儿童(BLINK2基线时年龄为11 - 17岁),他们完成了BLINK研究随机临床试验。入组时间为2019年9月至2021年1月;随访于2024年1月完成。在BLINK2研究中,所有儿童佩戴高加光(+2.50屈光度[D])多焦点软性隐形眼镜2年,并在第三年佩戴单焦点软性隐形眼镜,以确定是否发生反弹。
高加光多焦点软性隐形眼镜和单焦点软性隐形眼镜。
每年测量眼轴长度(光学生物测量)和屈光不正(睫状肌麻痹验光)。
在BLINK2研究入组的248名参与者中,235名完成了研究。基线访视时的中位年龄为15岁(范围11 - 17岁);146名参与者(59%)为女性,102名(41%)为男性。在BLINK2基线时,平均(标准差)眼轴长度和等效球镜屈光不正分别为25.2(0.9)mm和 - 3.40(1.40)D。参与者从多焦点隐形眼镜切换到单焦点隐形眼镜后,无论其最初的BLINK治疗分配如何,眼轴每年伸长增加0.03 mm(95%置信区间,0.01至0.05)(P = 0.81)。切换到单焦点镜片后近视进展每年增加 - 0.17 D(95%置信区间, - 0.22至 - 0.12),这也不依赖于最初的BLINK治疗分配(P = 0.57)。基于BLINK研究治疗分配,在整个BLINK2研究期间,眼轴长度和屈光不正仍存在差异,最初的高加光组比最初的中加光(+1.50 D)组和单焦点组眼轴更短、近视程度更低。
BLINK2研究未发现年龄较大青少年停用多焦点隐形眼镜后治疗效果丧失的证据。这些数据表明眼轴生长和近视进展恢复到更快但符合年龄预期的速率,并支持继续佩戴多焦点镜片直至眼轴伸长和近视进展停止。